REQUEST A DEMO
Total
USD $0.00
Search more companies

Be Vaccines Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Be Vaccines Pte. Ltd. Profile Updated: March 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Be Vaccines Pte. Ltd. is a company in Singapore, with a head office in Singapore. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on February 28, 2013. Below 50 (estimated) employees currently work for Be Vaccines Pte. Ltd.. From the latest financial highlights, Be Vaccines Pte. Ltd. reported a net sales revenue increase of 163.38% in 2025. Its’ total assets recorded a growth of 52.76%. The net profit margin of Be Vaccines Pte. Ltd. increased by 1.54% in 2025.

Legal Address
9 Raffles Place, #24-01, Republic Plaza, Singapore 048619
Singapore; Singapore; Postal Code: 048619

Contact Details: Purchase the Be Vaccines Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Be Vaccines Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Be Vaccines Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Be Vaccines Pte. Ltd. report to view the information.
Incorporation Date:
February 28, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director, Managing Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Qualivax Pte. Limited
50%
Company Performance
Financial values in the chart are available after Be Vaccines Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
163.38%
Total Operating Revenue
163.38%
Net Profit/Loss for the Period
223.51%
Total Assets
52.76%
Total Equity
62.98%
Net Profit Margin
1.54%
Return on Equity (ROE)
12.89%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?